Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chemische Fabrik Promonta was a Hamburg-based German chemical and pharmaceutical company that also manufactured cosmetic preparations. Historical records indicate it operated from 1919 until 1994, when it ceased as an independent entity. The company appears to have focused on marketed products rather than a modern disclosed R&D pipeline, and archival sources identify Promonta Lundbeck Arzneimittel GmbH & Co. as its successor. Lundbeck historical materials note that one Promonta-developed medicine, Lacumin, was licensed by Lundbeck in the 1950s, suggesting Promonta participated in commercial pharmaceutical product development. Overall, Promonta is best characterized as a historical European pharma manufacturer rather than an active contemporary biotech company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chemische Fabrik Promonta.